# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
JMP Securities analyst Devin Ryan maintains Hercules Capital (NYSE:HTGC) with a Market Outperform and raises the price targe...
Wells Fargo analyst Finian O'Shea maintains Hercules Capital (NYSE:HTGC) with a Overweight and raises the price target f...
Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and raises the price target from...
Keefe, Bruyette & Woods analyst Paul Johnson maintains Hercules Capital (NYSE:HTGC) with a Market Perform and raises the...
Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.50 per share which missed the analyst consensus estimate of $0.5...
Hercules Capital (NYSE:HTGC) reported quarterly earnings of $0.50 per share which met the analyst consensus estimate. This is a...
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company develo...
Piper Sandler analyst Crispin Love maintains Hercules Capital (NYSE:HTGC) with a Overweight and raises the price target from...